1l nalirifox in advanced or metastatic pdac
Published 3 years ago • 148 plays • Length 0:40Download video MP4
Download video MP3
Similar videos
-
0:54
napoli-3: first-line nalirifox in metastatic pancreatic ductal adenocarcinoma
-
1:28
nalirifox as frontline therapy for pdac
-
6:20
first-line nalirifox shows improvement in os and pfs in metastatic pancreatic cancer
-
1:15
optimizing first line treatment in metastatic pancreatic cancer
-
4:36
phase i/ii results: first-line nalirifox in patients with pancreatic ductal adenocarcinoma
-
0:52
neo-nal-iri: liposomal irinotecan 5-fu & oxaliplatin in panceratic cancer
-
1:12
elucidating the optimal second-line therapy in metastatic pancreatic cancer
-
0:54
targeting local recurrence in pancreatic adenocarcinoma with proton therapy
-
1:40
early diagnosis in advanced pancreatic cancer: how will we achieve this?
-
1:05
dr. o’hara on rationale for apx005m/chemotherapy and nivolumab in pancreatic cancer
-
4:04
recent advances in the management of pancreatic cancer
-
4:04
alliance trials: combination of modified folfirinox and radiotherapy for pancreatic cancer
-
2:33
precision medicine approaches in pancreatic cancer
-
5:47
choosing frontline therapy in metastatic disease
-
4:09
unresectable metastatic pancreatic cancer: a case review
-
1:43
liposomal irinotecan fluorouracil/leucovorin after progression in mpdac
-
5:50
immunotherapy with radiation in metastatic pancreatic and colorectal adenocarcinoma
-
18:33
gemcitabine monotherapy vs. doublet therapy vs. folfirinox for metastatic pancreatic adenocarcinoma
-
0:47
phase ii giant trial insights: managing older adults with metastatic pancreatic cancer